GSK-3-selective inhibitors derived from Tyrian purple indirubins (Q27642879)

scientific article

Language	Label	Description	Also known as
English	GSK-3-selective inhibitors derived from Tyrian purple indirubins	scientific article

Statements

instance of

scholarly article

0 references

title

GSK-3-selective inhibitors derived from Tyrian purple indirubins (English)

0 references

author

Paul Greengard

series ordinal

16

0 references

Andrea Musacchio

series ordinal

13

0 references

Prokopios Magiatis

object named as

Prokopios Magiatis

series ordinal

3

0 references

Alexios-Leandros Skaltsounis

series ordinal

2

object named as

Alexios-Leandros Skaltsounis

0 references

Ali Hemmati-Brivanlou

series ordinal

9

object named as

Ali Brivanlou

0 references

Laurent Meijer

series ordinal

1

object named as

Laurent Meijer

0 references

author name string

Panagiotis Polychronopoulos

series ordinal

4

0 references

Marie Knockaert

series ordinal

5

0 references

Maryse Leost

series ordinal

6

0 references

Xiaozhou P Ryan

series ordinal

7

0 references

Claudia Alin Vonica

series ordinal

8

0 references

Rana Dajani

series ordinal

10

0 references

Claudia Crovace

series ordinal

11

0 references

Cataldo Tarricone

series ordinal

12

0 references

S Mark Roe

series ordinal

14

0 references

Laurence Pearl

series ordinal

15

0 references

publication date

December 2003

0 references

published in

Chemistry and Biology

0 references

volume

10

0 references

page(s)

1255-66

0 references

issue

12

0 references

cites work

Wnt signaling in Xenopus embryos inhibits bmp4 expression and activates neural development

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Structure of GSK3beta reveals a primed phosphorylation mechanism

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

GSK3beta signalling: casting a wide net in Alzheimer's disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

The GSK3 beta signaling cascade and neurodegenerative disease.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Identification of an indigo precursor from leaves of Isatis tinctoria (Woad).

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Recruitment of dioxin receptor to active transcription sites

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

GSK-3: tricks of the trade for a multi-tasking kinase

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Glycogen synthase kinase 3: an emerging therapeutic target

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Cdk5 is a key factor in tau aggregation and tangle formation in vivo.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Structure and regulation of the CDK5-p25(nck5a) complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Siamois is required for formation of Spemann's organizer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Tau as a drug target in Alzheimer's disease.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Alzheimer's disease: targets for drug development

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Wnt signal transduction: kinase cogs in a nano-machine?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

The specificities of protein kinase inhibitors: an update

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Intracellular Targets of Paullones. Identification following affinity purification on immobilized inhibitor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Specificity and mechanism of action of some commonly used protein kinase inhibitors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Latest developments in crystallography and structure-based design of protein kinase inhibitors as drug candidates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Tyrian Purple: 6,6’-Dibromoindigo and Related Compounds

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

New aspects of Wnt signaling pathways in higher vertebrates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Wnt signaling involvement in beta-amyloid-dependent neurodegeneration.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Head induction by simultaneous repression of Bmp and Wnt signalling in Xenopus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

The renaissance of GSK3

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Wnt signaling controls the phosphorylation status of beta-catenin.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

Oxidation of indole by cytochrome P450 enzymes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CHEMBIOL.2003.11.010

GSK-3-selective inhibitors derived from Tyrian purple indirubins (Q27642879)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

GSK-3-selective inhibitors derived from Tyrian purple indirubins (Q27642879)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search